Publications

Original Articles and Reviews

GIULIANO F.

Phosphodiesterase Type 5 Inhibitors Improve Male Lower Urinary Tract Symptoms. Eur Urol. – 2008 : 53(6), 1121-1123

GIULIANO F.

Lower urinary tract symptoms and sexual dysfunction:a common approach BJU Int. – 2008 : 101 , suppl 3 , 22 – 26

GIULIANO F.

New horizons in erectile and endothelial dysfunction research and therapies Int J Impot Res. – 2008 : 20(S2):S2-S8

GIULIANO F.

Medical treatments for benign prostatic hyperplasia and sexual function BJU Int. – 2008 : Nov;102:8-12

GIULIANO F.

Mechanism of Action of PDE5 Inhibitors in LUTS and ED: the NO-cGMP Pathway. Eur Urol. – 2008 : 55(1):49-51

J. MAIGNEL, V. MARTIN, R. ASSALY, M. L. VOGT, K K. RETAILLEAU, A. LAUGEROTTE, S. LEZMI, P. DENYS, J. KRUPP AND C. JOUSSAIN

BoNT/A1 Secondary Failure for the Treatment of Neurogenic Detrusor Overactivity: An Ex Vivo Functional Study Toxins – 2022 : 14(2), 77

ASSALY R, FAUGEROUX J, LAURIN M, COMPAGNIE S, ALEXANDRE L, GIULIANO F, BEHR-ROUSSEL D

Silodosin improves functional consequences of lower urinary tract obstruction secondary to benign prostate hypertrophy, a proof of concept study in the spontaneously hypertensive rat supplemented with testosterone BMC Urology – 2020 : Aug 27;20(1):132

C. LEFÈVRE, A. BESSARD, P. AUBERT, C. JOUSSAIN, F. GIULIANO, D. BEHR-ROUSSEL, M-A. PERROUIN-VERBE, B. PERROUIN-VERBE, C. BROCHARD AND M. NEUNLIST

Enteric Nervous System Remodeling in a Rat Model of Spinal Cord Injury: A Pilot Study Neurotrauma Reports – 2020 : 1(1):41

HUYNH LE MAUX A, PIGNOL B, BEHR-ROUSSEL D, BLACHON JL, CHABRIER PE, COMPAGNIE S, PICAUT P, BERNABE J, GIULIANO F, DENYS P.

Does Reduction of Number of Intradetrusor Injection Sites of aboBoNTA (Dysport®) Impact Efficacy and Safety in a Rat Model of Neurogenic Detrusor Overactivity? Toxins – 2015 : Dec 17;7(12):5462-71

OGER-ROUSSEL S, BEHR-ROUSSEL D, CAISEY S, KERGROAT M, CHARON C, AUDET A, BERNABE J, ALEXANDRE L, GIULIANO F.

Bladder and erectile dysfunctions in the type 2 diabetic Goto-Kakizaki rat. Am J Physiol Regul Integr Comp Physiol – 2014 :  Jan 15;306(2):R108-17

ANDREEV-ANDRIEVSKIY A, LOMONOSOV M, POPOVA A, LAGEREVA E, CLÉMENT P, SALIMOV R, GOLIKOV D.

BP101 Peptide Promotes Female Sexual Receptivity in the Rat. J Sex Med. 2017 Mar;14(3):336-346

GELEZ H, GREGGAIN-MOHR J, PFAUS JG, ALLERS KA, GIULIANO F.

Flibanserin treatment increases appetitive sexual motivation in the female rat J Sex Med. – 2013 : May;10(5):1231-9

GELEZ H, CLEMENT P, COMPAGNIE S, GORNY D, LAURIN M, ALLERS K, SOMMER B, GIULIANO F.

Brain neuronal activation induced by flibanserin treatment in female rats Psychopharmacology (Berl) – 2013 : 230(4):639-52

VAILATI S, MELLONI E, RISCASSI E, BEHR ROUSSEL D, SARDINA M.

Evaluation of the effects of a new intravaginal gel, containing purified bovine colostrum, on vaginal blood flow and vaginal atrophy in ovariectomized rat. Sex Med. – 2013 : Dec;1(2):35-43

PFAUS JG, KIPPIN T, CORIA-AVILA G, GELEZ H, AFONSO V, ISMAIL N, PARADA M.

Who, What, Where, When (and Maybe Even Why)? How the Experience of Sexual Reward Connects Sexual Desire,Preference, and Performance Arch Sex Behav – 2012 : Feb;41(1):31-62

OUDOT A., BEHR-ROUSSEL D., LE COZ O., POIRIER S., BERNABE J., ALEXANDRE L., GIULIANO F.

How does chronic sildenafil prevent vascular oxidative stress in insulin resistant rats? J Sex Med – 2010 : 7(1)p1:79-88

OUDOT A, BEHR-ROUSSEL D, COMPAGNIE S, CAISEY S, LE COZ O, GORNY D, ALEXANDRE L, GIULIANO F.

Endothelial dysfunction in insulin resistant rats is associated with oxidative stress and cox pathway dysregulation Physiol Res. – 2009 : 58(4):499-509

BEHR-ROUSSEL D, OUDOT A, COMPAGNIE S, GORNY D, LE COZ O, BERNABE J, WAYMAN C, ALEXANDRE L, GIULIANO F.

Impact of a Long-Term Sildenafil Treatment on Pressor Response in Conscious Rats With Insulin Resistance and Hypertriglyceridemia. Am J Hypertens. – 2008 : 21(11):1258-63

Pelvipharm

UFR Simone Veil - Santé
Université de Versailles St Quentin en Yvelines

2 Avenue de la Source de la Bièvre
     78180 Montigny-Le-Bretonneux
     FRANCE
  +331 704 293 39

 contact@pelvipharm.com
logo_ok
UFR Simone Veil - Santé
Université de Versailles St Quentin en Yvelines
2 Avenue de la Source de la Bièvre - 78180 Montigny-Le-Bretonneux FRANCE